🇺🇸 enalapril tablets in United States

17 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Pressure Increased — 2 reports (11.76%)
  2. Bradycardia — 2 reports (11.76%)
  3. Fatigue — 2 reports (11.76%)
  4. Hyperkalaemia — 2 reports (11.76%)
  5. Hypotension — 2 reports (11.76%)
  6. Off Label Use — 2 reports (11.76%)
  7. Vomiting — 2 reports (11.76%)
  8. Abdominal Pain — 1 report (5.88%)
  9. Acute Kidney Injury — 1 report (5.88%)
  10. Acute Myocardial Infarction — 1 report (5.88%)

Source database →

enalapril tablets in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is enalapril tablets approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for enalapril tablets in United States?

Istituto Auxologico Italiano is the originator. The local marketing authorisation holder may differ — check the official source linked above.